logo

For the Inventor, By the Inventor

Dublin, Ireland

Tonix Pharma Holdings Limited

USPTO Granted Patents = 19



Forward Citations = 115

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Marino Nebuloni (11 out of 13 patents)

silverMedal Patrizia Colombo (9 out of 9 patents)

bronzeMedal Seth Lederman (7 out of 32 patents)

4.  Stefano Luca Giaffreda (2 out of 9 patents)

5.  Enrico Modena (2 out of 2 patents)

6.  Serena Fabbroni (2 out of 4 patents)

7.  Michel Chiarucci (2 out of 4 patents)

8.  Mark T Edgar (2 out of 5 patents)

9.  Herb Harris (2 out of 2 patents)

10.  Herbert W Harris (2 out of 2 patents)

11.  Gregory M Sullivan (1 out of 1 patent)

12.  Giorgio Reiner (19 patents)

13.  Harry Brittain (0 patent)

14.  Harry Brittain (0 patent)

15.  Gregory Martin Sullivan (0 patent)


19 patents:

1. 11998516 - Methods and compositions for treating depression using cyclobenzaprine (2024-06-04),
2. 11839594 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2023-12-12),
3. 11826321 - Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions (2023-11-28),
4. 11737991 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2023-08-29),
5. 11026898 - Eutectic formulations of cyclobenzaprine hydrochloride (2021-06-08),
6. 10946027 - Tianeptine oxalate salts and polymorphs (2021-03-16),
7. 10864176 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2020-12-15),
8. 10864175 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2020-12-15),
9. 10736859 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2020-08-11),
10. 10722478 - Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine (2020-07-28),
11. 10449203 - Tianeptine oxalate salts and polymorphs (2019-10-22),
12. 10357465 - Eutectic formulations of cyclobenzaprine hydrochloride (2019-07-23),
13. 10322094 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2019-06-18),
14. 10117936 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2018-11-06),
15. 9956188 - Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride (2018-05-01),
Company Overview
Tonix Pharma Holdings Limited is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders and other serious conditions. The company specializes in the research and development of treatments that leverage its proprietary technology platforms, including those aimed at enhancing immune responses and addressing unmet medical needs. Headquartered in Dublin, Ireland, Tonix Pharma is committed to advancing its pipeline of drug candidates through rigorous scientific exploration and clinical evaluation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#69 in Dublin

#118 in Ireland

#32,693 in the World

Dublin, IE
Dublin, Ireland

Tonix Pharma Holdings Limited

Forward Citations = 115

12 inventors:

goldMedal Marino Nebuloni (11 out of 13 patents)

silverMedal Patrizia Colombo (9 out of 9 patents)

bronzeMedal Seth Lederman (7 out of 32 patents)

4.  Stefano Luca Giaffreda (2 out of 9 patents)

5.  Enrico Modena (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tonix Pharma Holdings Limited. Retrieved from https://idiyas.com/company/tonix-pharma-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…